Parthenolide inhibits cancer stem-like side population of nasopharyngeal carcinoma cells via suppression of the NF-κB/COX-2 pathway.
Parthenolide inhibits cancer stem-like side population of nasopharyngeal carcinoma cells via suppression of the NF-κB/COX-2 pathway.
复制标题
小白菊内酯通过抑制 NF-kappaB/COX-2 通路抑制鼻咽癌细胞的癌干样侧群
作者:
Liao K;Xia B;Zhuang QY;Hou MJ;Zhang YJ;Luo B;Qiu Y;Gao YF;Li XJ;Chen HF;Ling WH;He CY;Huang YJ;Lin YC;Lin ZN
Cancer stem cells play a central role in the pathogenesis of nasopharyngeal carcinoma and contribute to both disease initiation and relapse. In this study, cyclooxygenase-2 (COX-2) was found to regulate cancer stem-like side population cells of nasopharyngeal carcinoma cells and enhance cancer stem-like cells' characteristics such as higher colony formation efficiency and overexpression of stemness-associated genes. The regulatory effect of COX-2 on cancer stem-like characteristics may be mediated by ABCG2. COX-2 overexpression by a gain-of-function experiment increased the proportion of side population cells and their cancer stemness properties. The present study also demonstrated that in contrast to the classical chemotherapy drug 5-fluorouracil, which increased the proportion of side population cells and upregulated the expression of COX-2, parthenolide, a naturally occurring small molecule, preferentially targeted the side population cells of nasopharyngeal carcinoma cells and downregulated COX-2. Moreover, we found that the cancer stem-like cells' phenotype was suppressed by using COX-2 inhibitors NS-398 and CAY10404 or knocking down COX-2 with siRNA and shRNA. These findings suggest that COX-2 inhibition is the mechanism by which parthenolide induces cell death in the cancer stem-like cells of nasopharyngeal carcinoma. In addition, parthenolide exhibited an inhibitory effect on nuclear factor-kappa B (NF-κB) nucler translocation by suppressing both the phosphorylation of IκB kinase complex and IκBα degradation. Taken together, these results suggest that parthenolide may exert its cancer stem cell-targeted chemotherapy through the NF-κB/COX-2 pathway.
登录
查看更多内容
影响因子:
20.3
作者:
Guzman, ML;Neering, SJ;Jordan, CT
通讯作者:
Jordan, CT
影响因子:
4.1
作者:
Ma, Hsin-I;Chiou, Shih-Hwa;Sytwu, Huey-Kang
通讯作者:
Sytwu, Huey-Kang
影响因子:
20.3
作者:
Guzman, ML;Rossi, RM;Jordan, CT
通讯作者:
Jordan, CT
影响因子:
7.3
作者:
Habeeb, AG;Rao, PNP;Knaus, EE
通讯作者:
Knaus, EE
影响因子:
9.3
作者:
Annabi B;Laflamme C;Sina A;Lachambre MP;Béliveau R
通讯作者:
Béliveau R